{"id":"W4412552202","doi":"10.1007/s12325-025-03305-5","title":"Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration","year":2025,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Rheumatology; Axial spondyloarthritis; Quality of life (healthcare); Duration (music); Internal medicine; Signs and symptoms; Physical therapy; Arthritis; Psoriatic arthritis; Sacroiliitis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001265726,0.0002615163,0.0009825868,0.0001649682,0.0001661812,0.0003227597,0.000169932,0.0002152614,0.0008543192],"category_scores_gemma":[0.001272809,0.0001593756,0.0008107743,0.0001938853,0.0002127717,0.0003335108,0.0001869281,0.000429556,0.00009729467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001838289,"about_ca_system_score_gemma":0.0003271951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004100392,"about_ca_topic_score_gemma":0.001075188,"domain_scores_codex":[0.9995165,0.000234294,0.00007688365,0.00005726868,0.00005810987,0.00005691814],"domain_scores_gemma":[0.999173,0.0002337893,0.000336632,0.00005296914,0.00005047728,0.00015311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4310662,0.008745232,0.3183994,0.001706207,0.004968589,0.0004603071,0.0003927959,0.002108383,0.04526764,0.0001201927,0.00139917,0.1853659],"study_design_scores_gemma":[0.04448173,0.2087001,0.7382919,0.0001164342,0.001810772,0.0007929149,0.0001867945,0.001388841,0.002477234,0.0001144073,0.001604335,0.00003446747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962807,0.003013144,0.00007326962,0.00006394921,0.00001917046,0.00003678797,0.00009516635,0.000004829389,0.0004130275],"genre_scores_gemma":[0.998614,0.0006876111,0.0001558746,0.0001167904,0.00003741757,0.00003584291,0.0001629012,0.000001147716,0.000188505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001265726,"threshold_uncertainty_score":0.00669384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007269823551129115,"score_gpt":0.2827602829955768,"score_spread":0.2754904594444477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}